Advanced searches left 3/3

Metastatic Melanoma BRAF - U.S. Department of Veterans Affairs

Summarized by Plex Scholar
Last Updated: 03 February 2022

* If you want to update the article please login/register

Proximity of immune and tumor cells underlies response to BRAF/MEK-targeted therapies in metastatic melanoma patients.

Tumor cell cellularity in the TCGA-melanoma study contributed to improved survival in patients with early-stage melanoma.

Source link: https://doi.org/10.1038/s41698-021-00249-1

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions